Fig. 6.
Fig. 6. Platelet recovery after the second cycle of chemotherapy for patients administered PEG-rHuMGDF 0.3 to 5.0 μg/kg (▪, n = 21) or placebo (▵, n = 10) during the first cycle of chemotherapy, but no study drug in the second cycle. Recovery to platelets of at least 150 × 109/L was more rapid in the PEG-rHuMGDF group (P = .013).

Platelet recovery after the second cycle of chemotherapy for patients administered PEG-rHuMGDF 0.3 to 5.0 μg/kg (▪, n = 21) or placebo (▵, n = 10) during the first cycle of chemotherapy, but no study drug in the second cycle. Recovery to platelets of at least 150 × 109/L was more rapid in the PEG-rHuMGDF group (P = .013).

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal